A forty-six-year-old divisional head at a tier-one bank in Marina arrives at the emergency department of a private hospital in Ikoyi on a Wednesday evening with central chest tightness, a pulse of 118, blood pressure of 168/102, and a conviction — entirely reasonable given the symptoms — that he is having a heart attack. He is admitted, troponins are run, an electrocardiogram is performed and repeated at six and twelve hours, a stress echocardiogram is booked for the following morning. Every result is clean. The troponins are negative across three draws. The ECG is normal sinus throughout. The stress echocardiogram, performed by a careful cardiologist, demonstrates a structurally normal heart with adequate functional reserve. He is discharged on the Friday with a printed letter that uses the phrase non-cardiac chest pain and an out-clinic follow-up scheduled for six weeks.
The phrase is technically correct and clinically misleading. The chest pain was not a non-event. It was the legible end of an underlying condition that had been clinically active in him, in some measurable form, for somewhere between four and seven years, and that — left undiagnosed by the term that has just been printed on his discharge letter — will, in any honest reading of his trajectory, present him at the same emergency department again within twelve to eighteen months, possibly with a result that is no longer clean.
The condition is chronic sympathetic activation. The colloquial term for it is stress. The clinical literature has, over the last fifteen years, stopped treating it as a soft diagnosis, and the practice would argue that it is now the most under-diagnosed and most consequential cardiometabolic condition of the Nigerian professional class under sixty.
Stress as a measurable physiological state
The reason chronic stress is a diagnosis and not a complaint is that what it does to the body is now measurable, and what it does is not subtle. The sympathetic nervous system and the hypothalamic-pituitary-adrenal axis are designed to operate in pulses — a perceived threat, a cortisol and catecholamine surge, an autonomic response, a return to baseline once the threat resolves. The cardiovascular and metabolic consequences of the pulse are not pathological. They are the system working.
The pathology arises when the system never returns to baseline. The body that experiences chronic, low-amplitude, continuous sympathetic activation — the body that is processing twelve to fourteen hours of continuous deadline cycles, traffic, payroll pressure, family responsibility, and email arrival for years without ever achieving the parasympathetic recovery window the system requires — produces, measurably, a set of physiological changes that are no longer subtle and no longer reversible by a weekend off.
Resting sympathetic tone rises and stays high. Heart rate variability, a measure of vagal tone and one of the cleanest signals of autonomic recovery, falls. Cortisol, which is supposed to follow a sharp morning curve and a low evening plateau, flattens — high in the evening, blunted in the morning, with the diurnal rhythm progressively erased. Resting blood pressure climbs, with the nocturnal dipping pattern lost. Fasting glucose drifts upward as cortisol opposes insulin. The lipid panel shifts toward an atherogenic profile. Visceral fat accumulates preferentially. Inflammatory markers — high-sensitivity C-reactive protein, interleukin-6, fibrinogen — rise to a low, persistent, sub-clinical level that is, on the cohort data, an independent cardiovascular risk factor in its own right. None of this is invisible. All of it is measurable. None of it is what the average Nigerian primary-care annual physical is looking for.
This is the patient with the non-cardiac chest pain. He is not having a non-event. He is having the symptomatic manifestation of a multi-system physiological state that has been active in him for years and that the clinical workup, performed correctly within its frame, was not designed to capture.
Why the Lagos and Abuja stress profile is structurally different
There is a tendency in the global conversation about workplace stress to treat the condition as universal — a problem of modern professional life that looks the same in São Paulo, Singapore, Stockholm, and Lagos. The practice would argue, on the cohort it has followed for a decade, that the profile in Lagos and Abuja is structurally different from the profile in any of the Western financial centres in three specific ways, and the differences matter clinically.
The first is that the recovery windows are smaller. The executive in Stockholm whose working week is genuinely intense returns at the end of it to a household with functional infrastructure, predictable power, predictable traffic patterns, and a system that allows the parasympathetic recovery the autonomic system requires. The executive in Lagos whose working week is intense returns at the end of it to a household in which the recovery window is itself partially consumed by infrastructure management — the generator, the school run timed against traffic, the multi-stop weekend logistics that the resident of the city does not experience as logistics until he has to compare. The week never ends in the way the autonomic system needs it to end.
The second is that the cortisol stimuli are categorically broader. The Lagos professional is processing the stimuli his Western counterpart processes — deadlines, email, financial responsibility — plus a second-order layer of stimuli the Western counterpart largely does not process at all: macroeconomic instability, currency volatility, sustained personal-security awareness, frequent family-wide health-system engagement, the standing low-grade administrative friction of operating any business in the country. The system that is supposed to fire and reset is firing constantly and never fully resetting.
The third is that the genetic and phenotypic substrate the stress is acting on is more vulnerable, not less. The cardiovascular and metabolic responsiveness to sustained cortisol elevation in West African and African-diaspora cohorts is, in the published data, more pronounced than in the populations against which the global guidelines were calibrated. The hypertension produced by chronic stress in this cohort climbs faster, the diabetes appears earlier, the cardiovascular events present at younger ages, and the chest pain in the emergency department on a Wednesday evening is, in the demographic the practice serves, not a clinical curiosity. It is a presentation that the cardiology audit data from the major Lagos centres has been quietly recording at increasing volume across the last decade.
The conditions chronic stress is accelerating
The reason chronic sympathetic activation is a cardiometabolic diagnosis and not a behavioural one is that what it accelerates is the same list of conditions the standard executive screening matrix is built to catch. There are five conditions in particular for which the cohort data is now consistent, and in each of which chronic stress is independently — that is, after accounting for diet, sleep, weight, and exercise — a risk factor.
Hypertension is the most direct. Sustained sympathetic activation raises resting blood pressure and abolishes nocturnal dipping. The patient whose ambulatory monitor records a mean of 142/92 across the working day and 138/90 across the night, with no clinical evidence of secondary hypertension, is producing the trace of a chronically activated autonomic system. The trace responds to the antihypertensive incompletely. It responds to the autonomic intervention — sleep restoration, parasympathetic reset, structured offloading — completely.
Type 2 diabetes is the second. Chronic cortisol elevation opposes insulin in a dose-dependent way, and the HbA1c that has drifted from 5.6 to 6.4 in a forty-five-year-old who has not gained weight, has not changed his diet, and continues to exercise three times a week is the trace of a glucose handling system being progressively pushed by the wrong endocrine signal. The intervention is the same. Pharmacology helps. The autonomic reset is what reverses the trajectory.
Coronary artery disease is the third. The acceleration of atherosclerosis by chronic sympathetic activation — through hypertension, inflammation, endothelial dysfunction, and atherogenic dyslipidaemia — is, in the most recent meta-analyses of the prospective cohort data, an independent risk factor with effect sizes that are no longer disputed. The coronary artery calcium score in the forty-eight-year-old with no other risk factors and a CAC of 240 is, with surprising frequency, the patient whose remaining risk factor is the autonomic state his life has produced.
Atrial fibrillation, the fourth, is the arrhythmia of chronic sympathetic excess and has begun to present, in the practice, in successively younger Nigerian executives. The fifty-one-year-old who notices an irregular pulse at his desk, who has no structural heart disease, who is not hyperthyroid, and whose AF episodes terminate on weekends when he is at his village is, on the cohort pattern, a patient whose AF is autonomically driven.
The fifth is the constellation of sleep dysfunction, sexual dysfunction, gastrointestinal symptoms, and unexplained fatigue that primary care across the city continues to attribute to ageing, to lifestyle, to the patient's workload, and that is, in the autonomic frame, a coherent set of presentations of a single underlying physiological state. Each one of the complaints in isolation looks like a separate problem to be managed separately. Read together they describe one patient with one diagnosis whose clinical trace has been spread across five specialists.
The investigation that is actually appropriate
The clinical investigation of the patient who arrives with a non-cardiac chest pain discharge letter is not a repeat of the cardiac workup that has already returned clean. It is a workup of the autonomic and endocrine state that produced the symptom, and the practice runs it as a defined panel. A twenty-four-hour ambulatory blood pressure trace with overnight readings to characterise the dipping pattern. A diurnal cortisol profile — morning, afternoon, evening, and bedtime salivary or serum samples — to characterise the HPA-axis rhythm. A high-sensitivity C-reactive protein and a fasting lipid panel with fasting insulin and HOMA-IR to characterise the metabolic state. A home sleep study with low threshold for a formal polysomnogram. A heart rate variability assessment — increasingly available as part of routine cardiology follow-up — to characterise vagal tone. A structured intake of working hours, recovery windows, alcohol, caffeine, and sleep architecture, recorded as quantitatively as the laboratory bloods.
The panel does not require novel infrastructure. Every component of it is available in Lagos and Abuja. None of it is exotic. The patient who runs through it produces a trace that is interpretable, comparable across visits, and — most importantly — actionable in ways the non-cardiac chest pain discharge letter is not.
What the intervention actually looks like
The intervention that follows the diagnosis is not a prescription for relaxation, and the practice does not deliver it as one. It is a structured, sequenced, measurable programme that treats the autonomic state as the clinical target it is.
Sleep is the first lever and produces the largest single change. The patient whose average is moved from five and a half hours of fragmented sleep to seven hours of continuous sleep over a twelve-week protocol — caffeine cut-off, alarm management, evening light hygiene, alcohol restriction, and where indicated CPAP titration — produces, in the cohort data the practice has accumulated, the largest single fall in ambulatory blood pressure, the largest single rise in heart rate variability, and the largest single normalisation of the diurnal cortisol curve.
Aerobic and resistance training is the second lever. Structured exercise of the right intensity at the right frequency raises vagal tone, lowers resting heart rate, and shifts the cortisol curve back toward its appropriate diurnal shape. The patient who has been told to take exercise by an annual physical that did not specify what kind, in what dose, at what intensity, has not been told anything actionable. The patient who has been prescribed three sessions of zone-2 cardiovascular work and two sessions of compound-lift resistance training a week, monitored at twelve and twenty-four weeks against a heart rate variability trace, has been.
Pharmacological intervention is the third lever and is sometimes necessary. The patient whose ambulatory readings remain hypertensive after the autonomic interventions have done their work needs the antihypertensive. The patient with a frank anxiety disorder layered on top of the autonomic state needs the psychiatric assessment. The cardiometabolic frame does not displace the standard pharmacology. It contextualises it, and it makes the question of why is this patient's blood pressure not responding to the antihypertensive a question the clinic can actually answer.
The fourth lever, and the one most under-used in the executive demographic, is structural offloading — a defined reduction in the standing sympathetic load of the patient's working life, delivered by the patient and his organisation, against a measurable physiological endpoint. The conversation is not about taking it easier. It is about which board commitments are draining vagal tone faster than the system can replenish, which scheduled meetings are producing measurable cortisol spikes in the half-hour preceding them, and what the redesign of the working week would look like if it were treated as a clinical intervention with a measurable endpoint. The conversation is uncomfortable, and it is the conversation the patient with non-cardiac chest pain on his discharge letter has not yet been offered.
The honest close
The patient at the top of this piece returned to the practice three weeks after the emergency-department admission, with the discharge letter, the bewildered look of a man who has been told nothing was wrong with him, and the visceral memory of a Wednesday evening when something had been very obviously wrong with him. The full autonomic and metabolic panel was run within the following month. The ambulatory blood pressure averaged 148/95 with absent nocturnal dipping. The diurnal cortisol curve was inverted. The HbA1c was 6.2. The high-sensitivity CRP was 4.1. The Lipoprotein(a) was elevated. The home sleep study returned an apnoea-hypopnoea index of 19. He had been clinically ill, in a defined and measurable way, for an estimated five to seven years.
He is now, fourteen months in, on a CPAP at night, on an SSRI for the anxiety disorder that had been hiding under the autonomic state, on an antihypertensive titrated against an ambulatory trace that has improved to 128/82 with restored dipping, and on a structured exercise and sleep protocol monitored at twelve-week intervals against a heart rate variability that is now in a normal range. The HbA1c has settled at 5.7. The CRP is 1.2. He has not been back to the emergency department. He has not returned, in any clinically meaningful way, to the autonomic state that put him there in the first place.
The lesson, if there is one, is the lesson the discharge letter did not quite manage to write. Chronic stress is not a complaint about which the patient is to be reassured. It is a diagnosis about which the patient is to be treated. The condition is real, it is measurable, it acts on the cardiovascular and metabolic systems with effect sizes that have stopped being soft, and it accelerates the same set of asymptomatic diseases the executive screening matrix is built to catch. The non-cardiac chest pain on the discharge letter is not the absence of a diagnosis. It is the presence of one. The work of the serious cardiometabolic practice in Lagos and Abuja, increasingly, is to be the place that reads it as such.